New mRNA activators for Parkinson’s

Research evidence has suggested that in Parkinson’s there is some disruption to a process involved in protein production within cells. This process is known as ‘m6A mRNA methylation’, and activation of this process may protect nerve cells against Parkinson’s. Laboratory research has shown that supporting…


The lonafarnib pre-clinical trial

This research led by Professor Joe Mazzulli, will, it is hoped, give us a better understanding of how lonafarnib can reduce the build-up of the toxic protein alpha-synuclein which is a characteristic of Parkinson’s.


News Fundraising news

Two families take on London to Amsterdam cycle for Parkinson’s

On 27 April, the Mostyn and Postlethwaite families will be setting off from London to tackle the incredible 286 mile cycle to Amsterdam, raising much needed funds and awareness for Parkinson’s.


News Fundraising news

Cotty’s crown for Parkinson’s

We are delighted to announce the winner of our Jubilee Crown competition as 8 year old Cotty Vicary, who created this beautiful design to be used as part of our summer of Jubilee fundraising and to raise awareness for Parkinson’s.


News Fundraising news

Peter Burns and Vicky Knight – Fundraisers of the Year 2021

Cure Parkinson’s is delighted to announce the winner of the 2020 Fundraiser of the Year Award as the incredible Meriel Buxton. This award recognises a person who has ‘gone above and beyond’ to raise funds and/or awareness for Parkinson’s